Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR NewswireJan 9 21:30

PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?

Zacks Jan 3 01:30

Precigen Secures $79M Financing for 2025 Launch

TipRanksDec 31, 2024 05:48

Precigen Soars: Biologics License Application Submission For PRGN-2012 Targets First FDA-Approved Recurrent Respiratory Papillomatosis Treatment

BenzingaDec 31, 2024 01:31

Stifel Maintains Precigen(PGEN.US) With Buy Rating

Futu NewsDec 30, 2024 23:32 · Ratings

Precigen's Strategic Advances and Financial Strength Boost Market Position for PRGN-2012

TipRanksDec 30, 2024 22:45